Glucokinase (GK) is an enzyme that catalyzes the ATP-dependent phosphorylation of glucose to form glucose-6-phosphate, and it is a tightly regulated checkpoint in glucose homeostasis. The monomeric enzyme possesses a highly exotic kinetic profile, with a sigmoidal dependence on glucose, which has been the source of vigorous investigation and debate in the last several decades. This unique regulatory behavior can be thought of as a remarkable glucose sensor, which may result in hyperglycemia when it is not active enough and hypoglycemia when it is too active. This interdisciplinary study, which draws on small angle X-ray scattering (SAXS) integrated with atomistic molecular dynamics simulations and experimental glucose binding thermodynamics, I reveal the critical regulation of the glucose sensor is due to a solvent controlled switch. Moreover, this solvent controlled switch manifests a regulatory mechanism of GK; a specific local conformational change that leads to an enzyme structure that has a much more favorable solvation energy than most of the protein ensemble. These findings have direct implications for the design of small molecule GK activators as anti- diabetes therapeutics as well as for understanding how proteins can be designed to have built-in regulatory functions via solvation energy dynamics.
Elucidating enzyme catalytic power and protein-ligand dynamics of human glucokinase: the role of modern allostery
Abstract
Details
- Title: Subtitle
- Elucidating enzyme catalytic power and protein-ligand dynamics of human glucokinase: the role of modern allostery
- Creators
- Quinn Li - University of Iowa
- Contributors
- M. Ashley Spies (Advisor)M. Todd Washington (Committee Member)Adrian H. Elcock (Committee Member)Ernesto J. Fuentes (Committee Member)Brandon S. Davies (Committee Member)David L. Roman (Committee Member)
- Resource Type
- Dissertation
- Degree Awarded
- Doctor of Philosophy (PhD), University of Iowa
- Degree in
- Biochemistry
- Date degree season
- Summer 2018
- DOI
- 10.17077/etd.tirid699
- Publisher
- University of Iowa
- Number of pages
- xiv, 124 pages
- Copyright
- Copyright © 2018 Quinn Li
- Language
- English
- Date submitted
- 11/19/2018
- Description illustrations
- color illustrations
- Description bibliographic
- Includes bibliographical references (pages 21-124).
- Public Abstract (ETD)
Type 2 Diabetes (T2D) is a metabolic disorder characterized by elevated blood glucose levels. T2D raises public health concerns with approximately 387 million people diagnosed with diabetes globally. Human liver glucokinase (GK), the enzyme that lies at the interface of several important metabolic pathways, has attracted much research interests as a novel T2D drug target because insulin release via GK activation is coupled to plasma glucose levels in alleviating hypoglycemia associated with known oral antidiabetic drugs.
In this thesis, a clinically relevant hyperinsulinemic, hyperactive mutant of GK, which resides at the remote drug binding site that holds therapeutic significance, is examined by employing both experimental and computational methods to identify the source of allosteric regulation of human liver GK. The results of the thermodynamic parameters, global structural conformational changes and atomistic models of the hyperactive GK mutant suggest a plausible model which helps to elucidate the complex mechanism of allosteric activation of glucokinase. It is believed that a mechanistic understanding of the enzyme allostery of GK will benefit the development of innovative small molecule allosteric hits that are effective as potential therapeutics against diabetes.
- Academic Unit
- Biochemistry and Molecular Biology
- Record Identifier
- 9983776987802771